Reports for TEVA CANADA LIMITED
Formerly known as ACTAVIS PHARMA COMPANY
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
103 (48%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2023-06-19 | 2023-08-04 | 195621 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2023-06-08 | 2023-07-05 | 194151 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2023-06-16 | 2023-10-03 | 195103 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2023-07-27 | 2024-01-19 | 200290 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2020-07-14 | 2021-05-06 | 120309 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2023-06-08 | 2023-08-18 | 194148 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2020-07-14 | 2021-05-06 | 120306 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2023-06-19 | 2023-07-21 | 195443 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2023-07-20 | 2024-01-19 | 199398 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2020-07-14 | 2021-05-06 | 120303 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2024-01-11 | 2024-02-01 | 215731 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2023-11-23 | 2023-12-14 | 211322 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2021-09-09 | 2022-03-26 | 145449 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2023-02-02 | 2023-02-09 | 183425 |
| TEVA-ROSUVASTATIN | 5MG | TABLET | Resolved | 2020-07-14 | 2021-03-04 | 120312 |
| TEVA-ROSUVASTATIN | 5MG | TABLET | Resolved | 2020-07-14 | 2021-03-04 | 120315 |
| TEVA-ROSUVASTATIN | 5MG | TABLET | Resolved | 2020-07-14 | 2021-07-09 | 120318 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2019-08-22 | 2019-09-19 | 92157 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2023-11-16 | 2023-12-14 | 210437 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2019-06-18 | 2019-11-21 | 86920 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-12 | 2018-10-12 | 63943 |
| RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-19 | 2018-10-19 | 64891 |
| RATIO-LENOLTEC NO 1 | 300MG 8MG 15MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81362 |
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-METFORMIN | 850MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 120012 |
| RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-02-13 | 2020-02-13 | 106148 |
| RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2019-10-25 | 2019-10-26 | 97243 |
| RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2019-10-25 | 2019-10-26 | 97261 |
| RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
| RATIO-TAMSULOSIN | 0.4MG | CAPSULE (SUSTAINED-RELEASE) | Discontinued | 2018-10-19 | 2018-10-19 | 64917 |
| RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Discontinued | 2024-06-28 | 2024-06-29 | 231583 |
| TEVA-ACYCLOVIR | 400MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256125 |
| TEVA-ACYCLOVIR | 800MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256128 |
| TEVA-ACYCLOVIR | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256122 |
| TEVA-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2022-01-07 | 2022-01-07 | 152351 |
| TEVA-AMITRIPTYLINE | 50MG | TABLET | Discontinued | 2022-01-07 | 2022-01-07 | 152378 |
| TEVA-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2022-01-07 | 2022-01-07 | 152375 |
| TEVA-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2020-09-24 | 2020-09-24 | 124896 |